← BIO-RAD LABORATORIES, INC. BIO
Market Price
$356.33
Market Cap
$9.67B
P/E Ratio
12.79
Revenue (FY 2025)
↑0.7% YoY
$2.58B
3-Yr CAGR: -2.7%
Net Income
↑141.2% YoY
$759.90M
Net Margin: 29.4%
Free Cash Flow
↑29.4% YoY
$374.60M
FCF Yield: 3.87%
EPS (Diluted)
↑142.6% YoY
$27.85
Basic: $27.87
Return on Equity
Efficiency
10.2%
ROA: 26.1%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (BIO)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $2,068.2M | — | $1,138.1M | $28.1M | — | $0.95 | — | $216.4M | $75.0M | — |
| FY 2017 | $2,160.2M | +4.4% | $1,187.4M | $122.2M | +334.7% | $4.07 | +328.4% | $103.9M | $-7.4M | -109.9% |
| FY 2018 | $2,289.4M | +6.0% | $1,223.2M | $365.6M | +199.1% | $12.10 | +197.3% | $285.5M | $155.7M | +2,190.4% |
| FY 2019 | $2,311.7M | +1.0% | $1,257.0M | $1,758.7M | +381.0% | $58.27 | +381.6% | $457.9M | $359.4M | +130.9% |
| FY 2020 | $2,545.6M | +10.1% | $1,437.8M | $3,806.3M | +116.4% | $126.20 | +116.6% | $575.3M | $476.4M | +32.6% |
| FY 2021 | $2,922.5M | +14.8% | $1,640.7M | $4,245.9M | +11.6% | $140.56 | +11.4% | $656.5M | $535.7M | +12.4% |
| FY 2022 | $2,802.2M | -4.1% | $1,567.3M | $-3,627.5M | -185.4% | $-121.79 | -186.6% | $194.4M | $81.7M | -84.8% |
| FY 2023 | $2,671.3M | -4.7% | $1,426.9M | $-637.3M | +82.4% | $-21.82 | +82.1% | $374.9M | $218.3M | +167.3% |
| FY 2024 | $2,566.5M | -3.9% | $1,378.9M | $-1,844.2M | -189.4% | $-65.36 | -199.5% | $455.2M | $289.6M | +32.7% |
| FY 2025 | $2,583.2M | +0.7% | $1,339.9M | $759.9M | +141.2% | $27.85 | +142.6% | $532.2M | $374.6M | +29.4% |
Valuation
Market Price
$356.33
Market Cap
$9.67B
Enterprise Value
$10.34B
P/E Ratio
12.79
P/B Ratio
1.28
FCF Yield
3.87%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
51.87%
Operating Margin
1.83%
Net Margin
29.42%
Return on Equity (ROE)
10.20%
Return on Assets (ROA)
26.15%
Asset Turnover
0.89x
Revenue 3-Yr CAGR
-2.68%
Financial Health & Liquidity
Current Ratio
5.62
Cash Ratio
1.02
Debt / Equity
0.161
Debt / Assets
0.413
Cash & Equivalents
$529.80M
Total Debt
$1.20B
Book Value / Share
$278.52
Cash Flow Efficiency
Operating Cash Flow
$532.20M
Capital Expenditures (CapEx)
$157.60M
Free Cash Flow
$374.60M
OCF / Revenue
20.60%
FCF / Revenue
14.50%
FCF 3-Yr CAGR
66.15%
Per Share Metrics
EPS (Diluted)
$27.85
EPS (Basic)
$27.87
Dividends / Share
N/A
Book Value / Share
$278.52
EPS YoY Growth
142.61%
Balance Sheet (FY 2025)
Total Assets
$2.91B
Total Liabilities
$517.00M
Stockholders' Equity
$7.45B
Current Assets
$2.91B
Current Liabilities
$517.00M